Navigation Links
Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
Date:5/3/2010

SEATTLE, May 3 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER) today announced additional data from a Phase 2 trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, showing that patients treated with OMS103HP during arthroscopic meniscectomy surgery achieved statistically significant clinical benefits. OMS103HP is an investigational drug product that is added to arthroscopic irrigation solution and is designed to improve postoperative joint function and motion and reduce postoperative pain. Omeros plans to present these additional data tomorrow in its webcast presentation at the Deutsche Bank Health Care Conference at 2:50 p.m. EDT and, for those not attending, has provided the clinical trial results below.

About the Phase 2 Trial of OMS103HP

The Phase 2 clinical trial was a prospective, multicenter, double-blind, randomized, vehicle-controlled study. Of the 161 patients who were enrolled and treated, 143 patients met the predetermined surgical and data collection criteria and were included in the data analysis (71 OMS103HP and 72 vehicle). There were no significant differences in demographic characteristics between the two treatment groups.

Pain scores in the immediate 24-hour period and up to seven days postoperatively were measured using a validated, 100-point, visual analog scale (VAS). Range of motion assessments were made at baseline and day seven postoperatively. The protocol was amended to collect patient self reports using the Knee Injury and Osteoarthritis Outcome Score (KOOS), which consists of five subscale scores: symptoms, pain, activities of daily living, sport and recreation function, and knee-
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
2. Daniel K. Spiegelman Elected to Board of Directors of Omeros
3. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
4. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
7. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
8. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
9. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
10. Repligen Reports Notice of Allowance of a United States Patent Covering the Use of Uridine to Treat the Symptoms of Bipolar Disorder
11. Capstone Reports Additional High Grade Copper-Gold Results From Minto East
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015 MEDTEC China South 2015 came ... of MEDTEC China 2015, MEDTEC China South has been recognized ... out as a key event for the medical device manufacturing ... years of challenges, this year marks the successful return of the ... after the event first debuted there in 2005. ...
(Date:6/3/2015)...   Health Data Consortium (HDC) , a public-private partnership whose mission ... to improve health and healthcare, today announced Niall Brennan ... Office of Enterprise Data and Analytics at the Centers ... of this year,s Health Data Liberators Award ... ways to help improve the quality and value of ...
(Date:6/3/2015)...  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a ... expertise in opioid antagonists, announced today that Adapt ... overdose with intranasal naloxone, has commenced a rolling ... the United States Food and Drug Administration (FDA) ... drug intended to treat opioid overdose.  A rolling ...
Breaking Medicine Technology:MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 4Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3
... 18, 2011 Reportlinker.com announces that a ... its catalogue: China ... http://www.reportlinker.com/p0590608/China-Contract-Research-Organization-CRO-Industry-Report-2010-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc ... high R&D costs of new drugs worldwide, ...
... from Texas has invented a miraculous new medical laser ... inventions and scientific advancements in modern history. The miraculous ... organs to kill harmful germs and bacteria during surgical ... currently contribute to the estimated 100,000 annual deaths attributed ...
Cached Medicine Technology:China Contract Research Organization (CRO) Industry Report, 2010-2011 2China Contract Research Organization (CRO) Industry Report, 2010-2011 3China Contract Research Organization (CRO) Industry Report, 2010-2011 4China Contract Research Organization (CRO) Industry Report, 2010-2011 5New Life Saving Medical Invention Announced by Perry Felix 2
(Date:6/3/2015)... June 03, 2015 “ Harmony ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... that wants to improve some aspect of their life. , ... only for people with difficulties in their life. However, hypnotherapy ...
(Date:6/3/2015)... 03, 2015 Follow us on ... has revolutionized disease treatment on account of their better ... diseases, such as rheumatoid arthritis. The industry is expected ... traditional small molecule drugs to biopharmaceuticals over the coming ... cell and gene therapies, and recombinant proteins has attracted ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 On the heels ... $13 billion industry by 2020 ( click here to ... computer scientists believe Baltimore has the talent to ... in which genetic code and other biological data are collected ... disease. “Baltimore contains all the elements of a perfect ...
(Date:6/3/2015)... 03, 2015 Dr. Steven Reisman, a nationally ... Center ( http://www.newyorkcardiac.com ) located in NYC, announced today the ... his practice. In most cases, depending on the level of ... they call, they will be seen by a cardiologist that ... a cardiologist is to ensure that people who have an ...
(Date:6/3/2015)... WA (PRWEB) June 03, 2015 ... insurance exchange technology, has announced that CEO Jonathan Rickert ... Institute 2015 on June 4, 2015. The session ... digital technologies are disrupting traditional business models in health ... business value. , WHAT: Digital Transformation and the ...
Breaking Medicine News(10 mins):Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2
... which diet would work best for you, study suggests , WEDNESDAY, ... cut carbs or fats to lose weight? A DNA test using ... you, new research suggests. , Researchers from Stanford University used data ... women were assigned to one of four popular diets for a ...
... , ... ... ... ...
... ... ... ... ...
... Ill. -- A daily dose of vitamin D may just ... according to researchers at Loyola University Chicago Marcella Niehoff School ... months when days are short and more time is spent ... despite the nutrient,s widely reported health benefits," said Sue Penckofer, ...
... youth means trouble by mid-40s, despite activity levels, study finds , ... in their 20s and 30s are more apt to develop heart ... people who spent less time in front of the screen, a ... the worse news is that you can,t exercise the risk away. ...
... , ... ... ... ...
Cached Medicine News:Health News:A Cheek Swab to Choose Your Diet Plan? 2Health News:A Cheek Swab to Choose Your Diet Plan? 3Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 2Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 3Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 4Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 5Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 6Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 7Health News:Aspen Dental Announces Results of Its 'An Hour for Haiti' Employee Donation Program 2Health News:Aspen Dental Announces Results of Its 'An Hour for Haiti' Employee Donation Program 3Health News:Vitamin D lifts mood during cold weather months 2Health News:You Can't Exercise Away TV's Toll on the Heart 2Health News:You Can't Exercise Away TV's Toll on the Heart 3Health News:Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock 2Health News:Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock 3
... The VERSAPORT™ RT cannulas are all able ... systems packaged for use with the RT ... are all able to be used with ... with the RT system. The trocars include: ...
... trocar has a sharp linear blade and a ... VERSAPORT™ PLUS V2 trocar is available in 5 ... 5 mm-12 mm long sizes with a radiolucent ... has a sharp linear blade and a spring-loaded ...
... Auto Suture™ SPRING-GRIP™ single use nonconductive anchoring ... mm, 11 mm and 12 mm sizes ... and 5 mm, 5 mm-10 mm, 5 ... mm-15 mm sizes for use with the ...
... Access ...unlike any trocar system you've ever ... actually four systems in one designed ... adaptive to all of your needs., ... or dilating tip styles, OnePort™ can effectively ...
Medicine Products: